Next Article in Journal
Inactivation of the Pyrimidine Biosynthesis pyrD Gene Negatively Affects Biofilm Formation and Virulence Determinants in the Crohn’s Disease-Associated Adherent Invasive Escherichia coli LF82 Strain
Previous Article in Journal
Genetic Diversity and Relationships of Listeria monocytogenes Serogroup IIa Isolated in Poland
Previous Article in Special Issue
Effects of Aspergillus fumigatus Conidia on Apoptosis and Proliferation in an In Vitro Model of the Lung Microenvironment
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Aspergillus and Health

1
Reference Unit for Parasitic and Fungal Infections, Department of Infectious Diseases, National Institute of Health, 1649-016 Lisbon, Portugal
2
Instituto de Saúde Ambiental, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal
Microorganisms 2022, 10(3), 538; https://doi.org/10.3390/microorganisms10030538
Submission received: 7 February 2022 / Accepted: 16 February 2022 / Published: 28 February 2022
(This article belongs to the Special Issue Aspergillus and Health 1.0)
Among the filamentous fungi described as etiological agents of infection, Aspergillus is the most frequent agent of invasive mould disease, and it is associated with high mortality. The Special Issue “Aspergillus and Health 1.0” intended to emphasize the enormous relevance of this agent as potential pathogen, and with this purpose, we gathered a diverse set of studies (nine research papers and two reviews) addressing Aspergillus epidemiology, prevalence, diagnosis, antifungal resistance, resistance mechanisms and virulence traits. In the following lines, the main topics of this Special Issue are revised, inviting all the readers to a deeper analysis of the published manuscripts.
An effective diagnosis of aspergillosis is complex and challenging. The development and validation of diagnostic tools and laboratorial methods to increase the accuracy to detect Aspergillus infection are always in the scope of scientific research. Culture remains the gold standard for the laboratory diagnosis of invasive fungal infections, including aspergillosis. Aiming to attain a higher sensitivity of cultures (especially in samples contaminated with different fungal genera), Zhang et al. [1] suggested the use of Flamingo Medium as an efficient method for the isolating A. fumigatus, especially from tissue contaminated with fungi belonging to Mucorales order. The authors reported that, using Flamingo Medium, they were able to recover an average of 20−30% more A. fumigatus colonies compared to other media, and at the same time, a 95% reduction in the number of Mucorales colonies was also observed. Also with the purpose of improving the diagnosis of aspergilosis, Cerqueira et al. [2] presented a method developed for detection of A. fumigatus sensu stricto in respiratory samples using peptide nucleic acid-fluorescence in situ hybridization (PNA-FISH). The sensitivity of the tested probe was 100% in strains but 79% in clinical samples, with a specificity of 100% in both cases. This study showed the potential of the PNA-FISH method for A. fumigatus sensu stricto detection, although more developments need to be done in order to achieve higher sensitivity in clinical samples.
The genus Aspergillus has been subject to a large number of taxonomic studies using DNA sequence data. Molecular characterization of Aspergillus has been contributing to the knowledge of molecular epidemiology, to the discovery of new etiological agents and to the understanding of species distribution. Climatic and geographic conditions may be important determinants of the local prevalence and distribution of Aspergillus species, which contribute to a diverse epidemiology among regions. Aiming to address some of these questions, Dietel et al. [3] performed a one-year study collecting environmental samples in Tyrol, Austria. Given the high frequency of aspergillosis cases caused by A. terreus in Austria, the authors aimed to perceive its ecological niche, distribution and association with clinical cases. They concluded that soil from agricultural cornfields seems to be an important source of A. terreus and that the environmental frequency of A. terreus correlates with the high incidence of A. terreus infections in certain geographical areas. Genotypic studies were also performed and allowed the identification of three major genotypes in Tyrol, with an elevated percentage of the studied isolates resistant to several antifungals, especially to amphotericin B (AMB).
Interestingly, Fan et al. [4] also focused their study in the high rate of AMB resistance but in A. fumigatus isolates. Using a whole genome approach in isolates from different sources, the single nucleotide polymorphisms (SNPs) were analysed, and three divergent genetic clusters were defined. These strains belonged to three divergent genetic clusters and 90% of AMB-resistant strains were located in one of those three clusters (cluster 2). More than 60 SNPs were significantly associated with AMB resistance, which may represent targets for the study of molecular mechanisms of resistance.
In addition, the high mortality rate in immunocompromised patients, significant pulmonary pathology is also associated with Aspergillus-induced allergic and asthmatic lung disease related to occupational exposure, associated with local epidemiology. Having this in mind, Sánchez Espinosa et al. [5] identified species of the genus Aspergillus obtained from the indoor environment of houses located in different municipalities of Havana, Cuba. The dust, walls and air of houses with history of moisture were collected and the diversity and richness of the isolated Aspergillus were analysed. The application of molecular methods for achieving the correct species identification within a specific Aspergillus section allowed the detection of numerous cryptic species and the identification of 15 species that have never been identified from the environment in Cuba. According to the authors, in addition to contributing to the knowledge of fungal biodiversity and ecology, those findings constitute an alert for the health authorities, since prolonged exposure of the inhabitants to mouldy houses can cause severe persistent asthma, among other diseases.
Azole resistance has been increasing in prevalence in A. fumigatus isolates due to the development of acquired resistance caused by prophylaxis/treatment with antifungals, as well as to the use of agricultural azoles and consequent acquisition of resistant isolates from environmental origin, posing new challenges in therapeutic management. In occupational environments where high fungal loads are expected, there is an increased risk of human exposure and infection, with impact on treatment success and disease outcome. Within that scope, in the study presented by Gonçalves et al. [6], 99 A. fumigatus isolates collected from indoor environments were screened for azole resistance and 3% of those isolates were pan-azole-resistant, bearing the TR34/L98H mutation. Resistant isolates were collected from an air sample from a diary and from disposable filtering respiratory protective devices worn by workers of a waste sorting plant. For the first time in Portugal, resistant isolates were detected from occupational environments, highlighting the importance of these local epidemiological studies on implementation of control policies that may have impact on occupational and public health. Following the subject of azole resistances in A. fumigatus, the review published by Melo et al. [7] discusses the emergence of azole resistance on Aspergillus considering the One Health Context. The authors propose that birds can play an important role in the dispersion of Aspergillus, and of special concern, azole-resistant strains, since avian species are involved in short and long distances travel between different types of landscapes, such as agricultural fields, where agricultural azole pesticides are used and may induce azole resistances.
The field of research on antifungal resistances is always a hot topic for the management of Aspergillus infections. In the work published by Schwarz et al. [8], the in vitro interactions of isavuconazole in combination with colistin were evaluated against A. flavus, A. fumigatus, A. nidulans, A. niger and A. terreus. Colistin is a drug with activity against multidrug-resistant gram-negative bacteria, and this study showed that colistin enhances the in vitro activity of isavuconazole against clinical A. nidulans and A. niger isolates with high in vitro MICs to isavuconazole using the EUCAST broth microdilution checkerboard methodology. On the other hand, by using an agar diffusion assay method, the susceptibility of A. nidulans was not affected by isavuconazole in combination with colistin, whereas only some of the A. niger isolates were. These studies on possible synergies are promising since they can help to establish new management approaches.
One of those studied species, Aspergillus nidulans, seems to have a remarkable association with chronic granulomatous disease patients and with mycotoxin production and these features have been raising the awareness on this species and its possible role in pathogenesis. Ye-Eun Son et al. [9] observed, by transcriptomic analysis, that the product codified by the gene vadA affects the mRNA expression of a variety of genes in A. nidulans conidia. The genes that were primarily affected in conidia were associated with trehalose biosynthesis, cell-wall integrity, stress response, and secondary metabolism. Additionally, the deletion of vadA led to an increase in the amount of the mycotoxin sterigmatocystin in the conidia. Data obtained in this study suggest that VadA coordinates conidia maturation, stress response, and secondary metabolism in A. nidulans conidia.
The inhalation of Aspergillus conidia and their airway deposition occurs every day. Aspergillus disease is characterized either by damage from the fungus itself or through an exaggerated inflammatory response of the host, depending also on the underlying immune status of the host. A high frequency of patients with chronic respiratory disease, such as interstitial pneumonia or pulmonary fibrosis, do not develop any kind of Aspergillus infection, despite the colonization of their airways. Thus, the study published by Kushima et al. [10] intended to determine the role of A. fumigatus colonization in pulmonary fibrosis by using heat-inactivated conidia for the infection of human lung epithelial cells and of murine embryo fibroblast cells in 2D and 3D cultures, analysing the process by RNA-sequencing. The authors concluded that A. fumigatus affects both apoptosis of epithelial cells and the growth of fibroblasts.
Other group of patients with respiratory disease are the patients with cystic fibrosis (CF), whose impaired mucociliary clearance and airways are filled with thick mucus and where the inhaled Aspergillus conidia are easily trapped. Susceptibility to Aspergillus-related lung disease in CF is reflected by clinical phenotypes ranging from persistent Aspergillus infection and bronchitis to allergic and airway invasive aspergillosis. Given the major importance of these patients, Margalit et al. [11] published a review on polymicrobial interactions that occur in the pulmonary tract of CF patients. The authors review the agonistic and antagonistic interactions that occur between A. fumigatus and pulmonary bacterial pathogens such as Pseudomonas aeruginosa. According to the revised studies, although bacteria may predominate in a competitive environment, A. fumigatus has the capacity to persist and contribute to disease.
Despite very different in their content, all the manuscripts published in this Special Issue followed the proposed conductive line on Aspergillus and Health and discussed the most recent insights on this area.
As such, I would like to thank to all the authors who contributed with their excellent papers to this Special Issue and to the reviewers for their time and expertise in examining and commenting on the manuscripts. Thanks also to the staff of the Microorganisms’ Editorial Office for their management and organization of this Special Issue. Given the elevated participation in this issue, we have the pleasure to launch the Special Issue “Aspergillus and Health 2.0”, to which all are invited to contribute with prominent research.

Funding

This research received no external funding.

Conflicts of Interest

The author declares no conflict of interest.

References

  1. Zhang, J.; Debets, A.J.M.; Verweij, P.E.; Schoustra, S.E. Selective Flamingo Medium for the Isolation of Aspergillus fumigatus. Microorganisms 2021, 9, 1155. [Google Scholar] [CrossRef] [PubMed]
  2. Cerqueira, L.; Moura, S.; Almeida, C.; Vieira, M.J.; Azevedo, N.F. Establishment of a New PNA-FISH Method for Aspergillus fumigatus Identification: First Insights for Future Use in Pulmonary Samples. Microorganisms 2020, 8, 1950. [Google Scholar] [CrossRef]
  3. Dietl, A.-M.; Vahedi-Shahandashti, R.; Kandelbauer, C.; Kraak, B.; Lackner, M.; Houbraken, J.; Lass-Flörl, C. The Environmental Spread of Aspergillus terreus in Tyrol, Austria. Microorganisms 2021, 9, 539. [Google Scholar] [CrossRef] [PubMed]
  4. Fan, Y.; Wang, Y.; Xu, J. Comparative Genome Sequence Analyses of Geographic Samples of Aspergillus fumigatus—Relevance for Amphotericin B Resistance. Microorganisms 2020, 8, 1673. [Google Scholar] [CrossRef] [PubMed]
  5. Sánchez Espinosa, K.C.; Almaguer Chávez, M.; Duarte-Escalante, E.; Rojas Flores, T.I.; Frías-De-León, M.G.; Reyes-Montes, M.d.R. Phylogenetic Identification, Diversity, and Richness of Aspergillus from Homes in Havana, Cuba. Microorganisms 2021, 9, 115. [Google Scholar] [CrossRef] [PubMed]
  6. Gonçalves, P.; Melo, A.; Dias, M.; Almeida, B.; Caetano, L.A.; Veríssimo, C.; Viegas, C.; Sabino, R. Azole-Resistant Aspergillus fumigatus Harboring the TR34/L98H Mutation: First Report in Portugal in Environmental Samples. Microorganisms 2021, 9, 57. [Google Scholar] [CrossRef] [PubMed]
  7. Melo, A.M.; Stevens, D.A.; Tell, L.A.; Veríssimo, C.; Sabino, R.; Xavier, M.O. Aspergillosis, Avian Species and the One Health Perspective: The Possible Importance of Birds in Azole Resistance. Microorganisms 2020, 8, 2037. [Google Scholar] [CrossRef] [PubMed]
  8. Schwarz, P.; Djenontin, E.; Dannaoui, E. Colistin and Isavuconazole Interact Synergistically In Vitro against Aspergillus nidulans and Aspergillus niger. Microorganisms 2020, 8, 1447. [Google Scholar] [CrossRef] [PubMed]
  9. Son, Y.-E.; Park, H.-S. Genome Wide Analysis Reveals the Role of VadA in Stress Response, Germination, and Sterigmatocystin Production in Aspergillus nidulans Conidia. Microorganisms 2020, 8, 1319. [Google Scholar] [CrossRef] [PubMed]
  10. Kushima, H.; Tsunoda, T.; Matsumoto, T.; Kinoshita, Y.; Izumikawa, K.; Shirasawa, S.; Fujita, M.; Ishii, H. Effects of Aspergillus fumigatus Conidia on Apoptosis and Proliferation in an In Vitro Model of the Lung Microenvironment. Microorganisms 2021, 9, 1435. [Google Scholar] [CrossRef] [PubMed]
  11. Margalit, A.; Carolan, J.C.; Kavanagh, K. Bacterial Interactions with Aspergillus fumigatus in the Immunocompromised Lung. Microorganisms 2021, 9, 435. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Sabino, R. Aspergillus and Health. Microorganisms 2022, 10, 538. https://doi.org/10.3390/microorganisms10030538

AMA Style

Sabino R. Aspergillus and Health. Microorganisms. 2022; 10(3):538. https://doi.org/10.3390/microorganisms10030538

Chicago/Turabian Style

Sabino, Raquel. 2022. "Aspergillus and Health" Microorganisms 10, no. 3: 538. https://doi.org/10.3390/microorganisms10030538

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop